Adaptive Biotechnologies CorpADPT
Price$28.90Intrinsic value$11.9559% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $11.95median of 2 methodsbased on filings through 30 Jun 2026
Market Price $28.90Price as of 30 Sep 2026
Margin of Safety -58.7%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 12.7%
Volatility vs market (adjusted beta)1.73

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAdaptive Biotechnologies CorpADPTHealth Care
Valuation
P/E—
P/S14.8×
P/B31.7×
EV / Revenue14.2×
EV / EBITDA—
Profitability
Gross margin73.6%
Operating margin-27.1%
Net margin-20.7%
FCF margin-7.8%
Returns
ROE-44.7%
ROA-10.0%
ROIC—
Growth
Revenue growth (YoY)72.2%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.00×
Current ratio4.79×
Altman Z-Score3.3
Interest coverage-12.92×
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.